Skip to main content

Science + Tech

American Association for Cancer Research Annual Meeting 2019: Highlights from the Case CCC
            The 2019 American Association for Cancer Research (AACR) Annual Meeting will take place Friday, March 29 through Wednesday, April 3 in Atlanta, GA. The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and…
Drupal-Aside-Photo.png
The Ides of March
Far from presaging gloom, the Ides of March has just capped a wonderful two-week run for the School of Medicine.  Last Tuesday we learned that we were elevated a rank in the U.S. News & World Report rankings to #24 (and remained #1 in Ohio). In addition, two departments, Pediatrics and Internal…
Sumita%20Khatri.jpg
A Patient's Guide to Asthma
“Asthma is a chronic lung condition that affects the airways,” says Dr. Sumita Khatri, Research Subject Advocate in our CTSC program and co-director of the asthma center at the Cleveland Clinic . Asthma stems from inflammation that causes airways to narrow, producing symptoms such as cough,…
Match Day 2019 for CWRU medical students
Outlet: Cleveland.com
Medical Students Meet their “Match” when the Clock Strikes Noon
Today at noon, medical students–including those from Case Western Reserve School of Medicine and its Cleveland Clinic Lerner College of Medicine–opened envelopes to discover where their journey will take them for the next three to seven years as resident physicians. The National Residency Matching…
de Lima Named Chief, Division of Hematology and Oncology at University Hospitals
The Case Comprehensive Cancer Center extends congratulations to Marcos de Lima, MD for his recent promotion to Chief of Hematology and Oncology at University Hospitals Cleveland Medical Center and Seidman Cancer Center. Marcos de Lima, MD de…
nerve_block
Case Western Reserve University startup, NervGen Pharma, raises $7.5M from initial public offering
NervGen Pharma Corp., a Vancouver-based company founded to develop regenerative-medicine technology licensed from Case Western Reserve University, raised about $7.5 million ($10 million in Canadian dollars) from an initial public offering. Shares of NervGen began trading on the Canadian TSX…